Literature DB >> 21365766

Biological effects of MC2050, a quinazoline-based PARP-1 inhibitor, in human neuroblastoma and EBV-positive Burkitt's lymphoma cells.

Luciana Mosca1, Dante Rotili, Italo Tempera, Alessandra Masci, Mario Fontana, Roberta Chiaraluce, Paola Mastromarino, Maria d'Erme, Antonello Mai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365766     DOI: 10.1002/cmdc.201000536

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  5 in total

1.  From PARP1 to TNKS2 Inhibition: A Structure-Based Approach.

Authors:  Stefano Tomassi; Julian Pfahler; Nicola Mautone; Annarita Rovere; Chiara Esposito; Daniela Passeri; Roberto Pellicciari; Ettore Novellino; Martin Pannek; Clemens Steegborn; Alessandro Paiardini; Antonello Mai; Dante Rotili
Journal:  ACS Med Chem Lett       Date:  2020-02-03       Impact factor: 4.345

Review 2.  DABCO bond cleavage for the synthesis of piperazine derivatives.

Authors:  Azim Ziyaei Halimehjani; Elham Badali
Journal:  RSC Adv       Date:  2019-11-08       Impact factor: 4.036

3.  PARP-1 modulates amyloid beta peptide-induced neuronal damage.

Authors:  Sara Martire; Andrea Fuso; Dante Rotili; Italo Tempera; Cesare Giordano; Ivana De Zottis; Alessia Muzi; Patrizia Vernole; Grazia Graziani; Emanuela Lococo; Martina Faraldi; Bruno Maras; Sigfrido Scarpa; Luciana Mosca; Maria d'Erme
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

4.  Neuroprotective Effects of PARP Inhibitors in Drosophila Models of Alzheimer's Disease.

Authors:  Anna Maggiore; Assunta Maria Casale; Walter Toscanelli; Ugo Cappucci; Dante Rotili; Maddalena Grieco; Jean-Philippe Gagné; Guy G Poirier; Maria d'Erme; Lucia Piacentini
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

5.  Synthesis, antitumor activity, 3D-QSAR and molecular docking studies of new iodinated 4-(3H)-quinazolinones 3N-substituted.

Authors:  Marcia Pérez-Fehrmann; Víctor Kesternich; Arturo Puelles; Víctor Quezada; Fernanda Salazar; Philippe Christen; Jonathan Castillo; Juan Guillermo Cárcamo; Alejandro Castro-Alvarez; Ronald Nelson
Journal:  RSC Adv       Date:  2022-08-02       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.